Supporting new vaccine introduction decisions

Lessons learned from the Hib Initiative experience

R hajjeh, L Privor-Dumm, Karen Edmond, Rosalyn O'Loughlin, Sharmila Shetty, Ulla K Griffiths, A P Bear, Adam Cohen, A Chandran, A Schuchat, Edward (Kim) MULHOLLAND, M Santosham

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption took place, particularly among GAVI-eligible countries. Several factors contributed to the increase in Hib vaccine adoption, including support provided by the Hib Initiative, a project funded by the GAVI Alliance in 2005 to accelerate evidence-informed decisions for use of Hib vaccine. This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines.
Original languageEnglish
Pages (from-to)7123-7129
Number of pages7
JournalVaccine
Volume28
Issue number43
DOIs
Publication statusPublished - 8 Oct 2010

Fingerprint

Haemophilus influenzae type b
Haemophilus influenzae
Haemophilus Vaccines
Vaccines
vaccines
Developing Countries
developing countries

Cite this

hajjeh, R., Privor-Dumm, L., Edmond, K., O'Loughlin, R., Shetty, S., Griffiths, U. K., ... Santosham, M. (2010). Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience. Vaccine, 28(43), 7123-7129. https://doi.org/10.1016/j.vaccine.2010.07.028
hajjeh, R ; Privor-Dumm, L ; Edmond, Karen ; O'Loughlin, Rosalyn ; Shetty, Sharmila ; Griffiths, Ulla K ; Bear, A P ; Cohen, Adam ; Chandran, A ; Schuchat, A ; MULHOLLAND, Edward (Kim) ; Santosham, M. / Supporting new vaccine introduction decisions : Lessons learned from the Hib Initiative experience. In: Vaccine. 2010 ; Vol. 28, No. 43. pp. 7123-7129.
@article{3dbcf4145e46445288e12ef6d41b21df,
title = "Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience",
abstract = "The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption took place, particularly among GAVI-eligible countries. Several factors contributed to the increase in Hib vaccine adoption, including support provided by the Hib Initiative, a project funded by the GAVI Alliance in 2005 to accelerate evidence-informed decisions for use of Hib vaccine. This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines.",
author = "R hajjeh and L Privor-Dumm and Karen Edmond and Rosalyn O'Loughlin and Sharmila Shetty and Griffiths, {Ulla K} and Bear, {A P} and Adam Cohen and A Chandran and A Schuchat and MULHOLLAND, {Edward (Kim)} and M Santosham",
year = "2010",
month = "10",
day = "8",
doi = "10.1016/j.vaccine.2010.07.028",
language = "English",
volume = "28",
pages = "7123--7129",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier",
number = "43",

}

hajjeh, R, Privor-Dumm, L, Edmond, K, O'Loughlin, R, Shetty, S, Griffiths, UK, Bear, AP, Cohen, A, Chandran, A, Schuchat, A, MULHOLLAND, EK & Santosham, M 2010, 'Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience', Vaccine, vol. 28, no. 43, pp. 7123-7129. https://doi.org/10.1016/j.vaccine.2010.07.028

Supporting new vaccine introduction decisions : Lessons learned from the Hib Initiative experience. / hajjeh, R; Privor-Dumm, L; Edmond, Karen; O'Loughlin, Rosalyn; Shetty, Sharmila; Griffiths, Ulla K; Bear, A P; Cohen, Adam; Chandran, A; Schuchat, A; MULHOLLAND, Edward (Kim); Santosham, M.

In: Vaccine, Vol. 28, No. 43, 08.10.2010, p. 7123-7129.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Supporting new vaccine introduction decisions

T2 - Lessons learned from the Hib Initiative experience

AU - hajjeh, R

AU - Privor-Dumm, L

AU - Edmond, Karen

AU - O'Loughlin, Rosalyn

AU - Shetty, Sharmila

AU - Griffiths, Ulla K

AU - Bear, A P

AU - Cohen, Adam

AU - Chandran, A

AU - Schuchat, A

AU - MULHOLLAND, Edward (Kim)

AU - Santosham, M

PY - 2010/10/8

Y1 - 2010/10/8

N2 - The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption took place, particularly among GAVI-eligible countries. Several factors contributed to the increase in Hib vaccine adoption, including support provided by the Hib Initiative, a project funded by the GAVI Alliance in 2005 to accelerate evidence-informed decisions for use of Hib vaccine. This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines.

AB - The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption took place, particularly among GAVI-eligible countries. Several factors contributed to the increase in Hib vaccine adoption, including support provided by the Hib Initiative, a project funded by the GAVI Alliance in 2005 to accelerate evidence-informed decisions for use of Hib vaccine. This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines.

U2 - 10.1016/j.vaccine.2010.07.028

DO - 10.1016/j.vaccine.2010.07.028

M3 - Article

VL - 28

SP - 7123

EP - 7129

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 43

ER -

hajjeh R, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK et al. Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience. Vaccine. 2010 Oct 8;28(43):7123-7129. https://doi.org/10.1016/j.vaccine.2010.07.028